Notice of Clarification of Eligible Applicants for RFA-DK-13-009 "Type 1 Diabetes TrialNet Clinical Network Hub (U01)"

Notice Number: NOT-DK-13-014

Update: The following update relating to this announcement has been issued:

  • August 14, 2013 - See Notice NOT-DK-13-017. Notice of Availability of Webinar Questions and Answers.

Key Dates
Release Date: July 16, 2013

Related Announcements
RFA-DK-13-009

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice provides clarification and additional instructions for Section III.1 Eligible Applicants, Eligible Individuals.

RFA-DK-13-009 is intended to fund a new TrialNet unit separate from the TrialNet Coordinating Center. There should be no overlap of personnel between the Clinical Network Hub application and the currently funded TrialNet Coordinating Center. This restriction does not apply to subcontracts currently funded through the TrialNet Coordinating Center.

Please note that Section III.3 Additional Information on Eligibility and all other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Ellen Leschek, M.D.
Division of Diabetes, Endocrinology, and Metabolism
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-402-8291
Fax: 301-480-3503
Email: lescheke@mail.nih.gov